Electronic cigarettes

A task force report from the European Respiratory Society

Robert Bals, Jeanette Boyd, Susanna Esposito, Robert Foronjy, Pieter S. Hiemstra, Carlos A. Jiménez-Ruiz, Paraskevi Katsaounou, Anne Lindberg, Carlos Metz, Wolfgang Schober, Avrum Spira, Francesco Blasi

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

There is a marked increase in the development and use of electronic nicotine delivery systems or electronic cigarettes (ECIGs). This statement covers electronic cigarettes (ECIGs), defined as “electrical devices that generate an aerosol from a liquid” and thus excludes devices that contain tobacco. Database searches identified published articles that were used to summarise the current knowledge on the epidemiology of ECIG use; their ingredients and accompanied health effects; second-hand exposure; use of ECIGs for smoking cessation; behavioural aspects of ECIGs and social impact; in vitro and animal studies; and user perspectives. ECIG aerosol contains potentially toxic chemicals. As compared to conventional cigarettes, these are fewer and generally in lower concentrations. Second-hand exposures to ECIG chemicals may represent a potential risk, especially to vulnerable populations. There is not enough scientific evidence to support ECIGs as an aid to smoking cessation due to a lack of controlled trials, including those that compare ECIGs with licenced stop-smoking treatments. So far, there are conflicting data that use of ECIGs results in a renormalisation of smoking behaviour or for the gateway hypothesis. Experiments in cell cultures and animal studies show that ECIGs can have multiple negative effects. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.

Original languageEnglish
Article number1801151
JournalEuropean Respiratory Journal
Volume53
Issue number2
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Advisory Committees
Smoking
Smoking Cessation
Aerosols
Electronic Cigarettes
Tobacco
Hand
Equipment and Supplies
Poisons
Health
Vulnerable Populations
Social Change
Nicotine
Tobacco Products
Epidemiology
Cell Culture Techniques
Databases

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Bals, R., Boyd, J., Esposito, S., Foronjy, R., Hiemstra, P. S., Jiménez-Ruiz, C. A., ... Blasi, F. (2019). Electronic cigarettes: A task force report from the European Respiratory Society. European Respiratory Journal, 53(2), [1801151]. https://doi.org/10.1183/13993003.01151-2018

Electronic cigarettes : A task force report from the European Respiratory Society. / Bals, Robert; Boyd, Jeanette; Esposito, Susanna; Foronjy, Robert; Hiemstra, Pieter S.; Jiménez-Ruiz, Carlos A.; Katsaounou, Paraskevi; Lindberg, Anne; Metz, Carlos; Schober, Wolfgang; Spira, Avrum; Blasi, Francesco.

In: European Respiratory Journal, Vol. 53, No. 2, 1801151, 01.02.2019.

Research output: Contribution to journalReview article

Bals, R, Boyd, J, Esposito, S, Foronjy, R, Hiemstra, PS, Jiménez-Ruiz, CA, Katsaounou, P, Lindberg, A, Metz, C, Schober, W, Spira, A & Blasi, F 2019, 'Electronic cigarettes: A task force report from the European Respiratory Society', European Respiratory Journal, vol. 53, no. 2, 1801151. https://doi.org/10.1183/13993003.01151-2018
Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra PS, Jiménez-Ruiz CA et al. Electronic cigarettes: A task force report from the European Respiratory Society. European Respiratory Journal. 2019 Feb 1;53(2). 1801151. https://doi.org/10.1183/13993003.01151-2018
Bals, Robert ; Boyd, Jeanette ; Esposito, Susanna ; Foronjy, Robert ; Hiemstra, Pieter S. ; Jiménez-Ruiz, Carlos A. ; Katsaounou, Paraskevi ; Lindberg, Anne ; Metz, Carlos ; Schober, Wolfgang ; Spira, Avrum ; Blasi, Francesco. / Electronic cigarettes : A task force report from the European Respiratory Society. In: European Respiratory Journal. 2019 ; Vol. 53, No. 2.
@article{0a1102cede034db79ec93c458adffcde,
title = "Electronic cigarettes: A task force report from the European Respiratory Society",
abstract = "There is a marked increase in the development and use of electronic nicotine delivery systems or electronic cigarettes (ECIGs). This statement covers electronic cigarettes (ECIGs), defined as “electrical devices that generate an aerosol from a liquid” and thus excludes devices that contain tobacco. Database searches identified published articles that were used to summarise the current knowledge on the epidemiology of ECIG use; their ingredients and accompanied health effects; second-hand exposure; use of ECIGs for smoking cessation; behavioural aspects of ECIGs and social impact; in vitro and animal studies; and user perspectives. ECIG aerosol contains potentially toxic chemicals. As compared to conventional cigarettes, these are fewer and generally in lower concentrations. Second-hand exposures to ECIG chemicals may represent a potential risk, especially to vulnerable populations. There is not enough scientific evidence to support ECIGs as an aid to smoking cessation due to a lack of controlled trials, including those that compare ECIGs with licenced stop-smoking treatments. So far, there are conflicting data that use of ECIGs results in a renormalisation of smoking behaviour or for the gateway hypothesis. Experiments in cell cultures and animal studies show that ECIGs can have multiple negative effects. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.",
author = "Robert Bals and Jeanette Boyd and Susanna Esposito and Robert Foronjy and Hiemstra, {Pieter S.} and Jim{\'e}nez-Ruiz, {Carlos A.} and Paraskevi Katsaounou and Anne Lindberg and Carlos Metz and Wolfgang Schober and Avrum Spira and Francesco Blasi",
year = "2019",
month = "2",
day = "1",
doi = "10.1183/13993003.01151-2018",
language = "English",
volume = "53",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "2",

}

TY - JOUR

T1 - Electronic cigarettes

T2 - A task force report from the European Respiratory Society

AU - Bals, Robert

AU - Boyd, Jeanette

AU - Esposito, Susanna

AU - Foronjy, Robert

AU - Hiemstra, Pieter S.

AU - Jiménez-Ruiz, Carlos A.

AU - Katsaounou, Paraskevi

AU - Lindberg, Anne

AU - Metz, Carlos

AU - Schober, Wolfgang

AU - Spira, Avrum

AU - Blasi, Francesco

PY - 2019/2/1

Y1 - 2019/2/1

N2 - There is a marked increase in the development and use of electronic nicotine delivery systems or electronic cigarettes (ECIGs). This statement covers electronic cigarettes (ECIGs), defined as “electrical devices that generate an aerosol from a liquid” and thus excludes devices that contain tobacco. Database searches identified published articles that were used to summarise the current knowledge on the epidemiology of ECIG use; their ingredients and accompanied health effects; second-hand exposure; use of ECIGs for smoking cessation; behavioural aspects of ECIGs and social impact; in vitro and animal studies; and user perspectives. ECIG aerosol contains potentially toxic chemicals. As compared to conventional cigarettes, these are fewer and generally in lower concentrations. Second-hand exposures to ECIG chemicals may represent a potential risk, especially to vulnerable populations. There is not enough scientific evidence to support ECIGs as an aid to smoking cessation due to a lack of controlled trials, including those that compare ECIGs with licenced stop-smoking treatments. So far, there are conflicting data that use of ECIGs results in a renormalisation of smoking behaviour or for the gateway hypothesis. Experiments in cell cultures and animal studies show that ECIGs can have multiple negative effects. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.

AB - There is a marked increase in the development and use of electronic nicotine delivery systems or electronic cigarettes (ECIGs). This statement covers electronic cigarettes (ECIGs), defined as “electrical devices that generate an aerosol from a liquid” and thus excludes devices that contain tobacco. Database searches identified published articles that were used to summarise the current knowledge on the epidemiology of ECIG use; their ingredients and accompanied health effects; second-hand exposure; use of ECIGs for smoking cessation; behavioural aspects of ECIGs and social impact; in vitro and animal studies; and user perspectives. ECIG aerosol contains potentially toxic chemicals. As compared to conventional cigarettes, these are fewer and generally in lower concentrations. Second-hand exposures to ECIG chemicals may represent a potential risk, especially to vulnerable populations. There is not enough scientific evidence to support ECIGs as an aid to smoking cessation due to a lack of controlled trials, including those that compare ECIGs with licenced stop-smoking treatments. So far, there are conflicting data that use of ECIGs results in a renormalisation of smoking behaviour or for the gateway hypothesis. Experiments in cell cultures and animal studies show that ECIGs can have multiple negative effects. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.

UR - http://www.scopus.com/inward/record.url?scp=85061444585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061444585&partnerID=8YFLogxK

U2 - 10.1183/13993003.01151-2018

DO - 10.1183/13993003.01151-2018

M3 - Review article

VL - 53

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 2

M1 - 1801151

ER -